Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [Release No. 34-99355; File No. SR-NYSE-2023-09]

                    On September 27, 2023, New York Stock Exchange LLC (the “Exchange” or “NYSE”) filed with the Securities and Exchange Commission (“Commission”), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”) [1]                                          and Rule 19b-4 thereunder,[2]                                          a proposed rule change to amend the NYSE Listed Company Manual to adopt a new listing standard for the listing of Natural Asset Companies (“NAC”). The proposed rule change was published for comment in the                     **Federal Register**                     on October 4, 2023.[3]                                          On November 7, 2023, pursuant to Section 19(b)(2) of the Act,[4]                                          the Commission designated a longer period within which to approve the proposed rule change, disapprove the proposed rule change, or institute proceedings to determine whether to disapprove the proposed rule change.[5]                                          On December 21, 2023, the Commission instituted proceedings pursuant to Section 19(b)(2)(B) of the Act [6]                                          to determine whether to approve or disapprove the proposed rule change.[7]                                          On January 17, 2024, the Exchange withdrew the proposed rule change (SR-NYSE-2023-09).                

                        For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.[8] 
      ( print page 4355)    
 

Sherry R. Haywood,

Assistant Secretary.

# Footnotes

1.                             15 U.S.C. 78s(b)(1).                    
        Back to Citation      

2.                             17 CFR 240.19b-4.                    
        Back to Citation      

3.                                                     *See*                         Securities Exchange Act Release No. 98665 (Sept. 29, 2023), 88 FR 68811 (Oct. 4, 2023) (SR-NYSE-2023-09). Comments received on the NAC Proposal are available at                         *https://www.sec.gov/​comments/​sr-nyse-2023-09/​srnyse202309.htm.*
        Back to Citation      

4.                             15 U.S.C. 78s(b)(2).                    
        Back to Citation      

5.                                                     *See*                         Securities Exchange Act Release No. 98879 (Nov. 7, 2023), 88 FR 78075 (Nov. 14, 2023). The Commission designated January 2, 2024, as the date by which the Commission shall approve or disapprove, or institute proceedings to determine whether to disapprove, the proposed rule change.                    
        Back to Citation      

6.                             15 U.S.C. 78s(b)(2)(B).                    
        Back to Citation      

7.                                                     *See*                         Securities Exchange Act Release No. 99225 (Dec. 21, 2023), 88 FR 89788 (Dec. 28, 2023).                    
        Back to Citation      

8.                                 17 CFR 200.30-3(a)(12).                        
        Back to Citation      

[FR Doc. 2024-01189 Filed 1-22-24; 8:45 am]

BILLING CODE 8011-01-P